Moderna Inc

NASDAQ:MRNA  
199.21
-3.26 (-1.61%)
5:15:08 PM EDT: $198.11 -1.10 (-0.55%)
Products

Moderna Announces Initiation Of Rolling Submission Of Biologics License Application (BLA) With U.S. FDA For The Moderna Covid-19 Vaccine

Published: 06/01/2021 11:50 GMT
Moderna Inc (MRNA) - Moderna Announces Initiation of Rolling Submission of Biologics License Application (bla) With U.S. FDA for the Moderna Covid-19 Vaccine.
Moderna Announces Initiation of Rolling Submission of Biologics License Application (bla) With U.S. FDA for the Moderna Covid-19 Vaccine.
Moderna Inc - Will Continue to Submit Data to Support Bla to FDA on a Rolling Basis Over Coming Weeks With a Request for a Priority Review.
Moderna Inc - Once Rolling Bla Submission is Complete, FDA Will Notify Company When It is Formally Accepted for Review.
Moderna Inc - As of Today, According to U.S. Cdc, More Than 124 Million Doses of Moderna Covid-19 Vaccine Have Been Administered in U.S.